Hochschulschrift
HSP90 as a novel target therapy for the treatment of Hodgkin’s Lymphoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Köln, Univ., Diss., 2010
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Köln
- (who)
-
Deutsche Zentralbibliothek für Medizin
- (when)
-
2010
- Creator
- DOI
-
10.4126/38m-000000240
- URN
-
urn:nbn:de:hbz:38m-0000002408
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:56 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Eltaib, Farag Ibrahim
- Deutsche Zentralbibliothek für Medizin
Time of origin
- 2010
Other Objects (12)
Radiotherapy for Hodgkin lymphoma
Non-Hodgkin-Lymphome : Cytologie u. Cytochemie = Non-Hodgkin's lymphoma
Leukemia and non-Hodgkin lymphoma
Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma
T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
Role of FOXO3 in classical Hodgkin lymphoma
Mechanisms of NF-kB pathway activation in classical Hodgkin´s lymphoma
Autologous bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
Hodgkin lymphoma secreted factors determine macrophage polarization and function
Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma
Without Epstein Barr virus infection, no non Hodgkin lymphoma
Radiotherapy for Hodgkin lymphoma
Non-Hodgkin-Lymphome : Cytologie u. Cytochemie = Non-Hodgkin's lymphoma
Leukemia and non-Hodgkin lymphoma
Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma
T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
Role of FOXO3 in classical Hodgkin lymphoma
Mechanisms of NF-kB pathway activation in classical Hodgkin´s lymphoma
Autologous bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
Hodgkin lymphoma secreted factors determine macrophage polarization and function
Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma
Without Epstein Barr virus infection, no non Hodgkin lymphoma
Radiotherapy for Hodgkin lymphoma
Non-Hodgkin-Lymphome : Cytologie u. Cytochemie = Non-Hodgkin's lymphoma
Leukemia and non-Hodgkin lymphoma
Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma
T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
Role of FOXO3 in classical Hodgkin lymphoma
Mechanisms of NF-kB pathway activation in classical Hodgkin´s lymphoma
Autologous bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
Hodgkin lymphoma secreted factors determine macrophage polarization and function
Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma